The MILESTONE Study

计划入组 30 人 · 首次发布于 2019 年 9 月 11 日

MILESTONE - MobILe and tEchnological SoluTions for OccupatioNal drivErs

计划入组 160 人 · 首次发布于 2024 年 5 月 1 日

virtual reality on trunk control with developmental delays

计划入组 22 人

NMUR2 agonists (Takeda Pharmaceutical)

PL-1 (Protelight Pharmaceutical)

deoxyuridine triphosphatase inhibitors (Taiho Pharmaceutical)

MILESTONE PHARMACEUTICALS

India

Milestone Scientific

United States

The Trustee for Milestone Trust

Australia

Milestone Pharmaceuticals Gains New Patent for Etripamil, Prepares for Potential Launch

FDA Issues Complete Response Letter for Milestone Pharmaceuticals' Etripamil Nasal Spray

FDA Accepts Milestone's Cardamyst NDA for PSVT Treatment